Wednesday, February 10, 2010
First New Green Baron “Stock Pick” for 2010 Coming in One Week on Wednesday, February 17
Calendar: The Green Baron Report will release our 84th “Stock Pick” in exactly one week on Wednesday, February 17 after the close of trading. Green Baron Focus “Stock Picks” are considered our top level of coverage and usually rally huge after we release our initial profile. We have patiently waited for the right stock to present to our members this year, and we are now ready. This stock trades at about $5.00, but its P/E is extremely low. This pick will likely rocket many dollars per share. Be prepared to be amazed. Mark your calendar now!
Also, a “Trading Alert” Update will be released before the open tomorrow morning, Thursday, February 11. It looks like this “Trading Alert” stock is ready for another bounce.
“Stock Pick” Update
(BB: CAEH)
News Announced Yesterday
Caleco Pharma Corp. Engages ICF Kursmakler AG as Designated Sponsor on Frankfurt Stock Exchange and BlueWater Advisory Group LLC as Investor Relations Consultant
After the close of trading on October 13, 2009, The Green Baron Report issued its initial “Stock Pick” report making Caleco Pharma our 81st fully profiled stock pick at .18 per share. CAEH rallied in a big way afterwards with a move of as much as 94% to as high as .35 on October 23. In just 10 days, members could have recorded gains of nearly 100%. If you question these results, go back and look it up. Did we say a new “Stock Pick” is coming in a week?
Caleco has stayed at or above our profile price of .18 per share ever since we issued our initial report. It seems every time the stock gets near .20 per share, we see another rally, and it looks like history will repeat itself again. We understand Caleco remains very active, and we anticipate new developments soon. News announced yesterday indicates that the Company is focused on bringing its story to news markets and a wider audience. More investors typically translate into a higher stock price. See news reprinted below:
Feb 9, 2010 9:03:00 AM EST
BELLINGHAM, WASHINGTON--(Marketwire - Feb. 9, 2010) - Caleco Pharma Corp. (OTCBB:CAEH)(FRANKFURT:T3R)(WKN:A0N9Y0) ("Caleco Pharma") (www.calecopharmacorp.com) is pleased to announce that it has entered into a designated sponsorship agreement (the "Sponsorship Agreement") with ICF Kursmakler AG ("ICF Kursmakler"), a German investment bank that is a designated sponsor on Frankfurt Stock Exchange's Xetra trading platform, whereby ICF Kursmakler will act as the Company's sponsor on the Frankfurt Stock Exchange. As the Company's sponsor, ICF Kursmakler has agreed to provide additional liquidity of the Company's shares on the electronic Xetra trading system in accordance with the regulations of theFrankfurt Stock Exchange.
The term of the Sponsorship Agreement commences on March 1, 2010. Either party may terminate the Sponsorship Agreement without cause at the end of each quarter on six weeks notice. Neither party may terminate the Sponsorship Agreement prior to March 1, 2011.
Engagement of BlueWater Advisory Group
The Company is also pleased to announce that it has entered into a consulting agreement with BlueWater Advisory Group, LLC ("BlueWater") whereby BlueWater has agreed to provide the Company with investor relations services.
The investor relations services to be provided by BlueWater include, among other things: the development of the Company's investor relation strategies; preparation of executive summaries and corporate profiles; assisting in the preparation of news releases; assisting the Company in incorporating its investor relations strategy in the corporate website, and other steps to enhance the company's visibility among investors, analysts and portfolio managers.
In consideration of these services, the Company has agreed to pay BlueWater $3,500 per month, reimburse BlueWater for all out-of-pocket expenses incurred in connection with this agreement and issue to BlueWater 300,000 restricted shares of the Company's common stock pursuant to Rule 506 of Regulation D of the Securities Act of 1933.
Either party may terminate the consulting agreement upon five days written notice.
About Caleco Pharma Corp.
Caleco Pharma is focused on the ongoing research and development of its broad pipeline of over-the-counter and prescription medications including its proprietary "Liver Health Formula" technology designed to treat moderate to severe liver maladies, including Hepatitis C viral infection. In addition Caleco Pharma is developing Food Supplements and over-the-counter Dermatological Products based on the active ingredients found in the Liver Health Formula. To date, Caleco Pharma's intellectual property covering the Liver Health Formula comprises of patent applications in the United States, Europe and Canada and four European Drug Master File applications.
Caleco Pharma's shares are traded in the United States on the OTC Bulletin Board (OTCBB:CAEH) and in Germany on the Frankfurt Stock Exchange (FRANKFURT:T3R)(WKN:A0N9Y0).
This press release may contain, in addition to historic information, forward-looking statements. These statements may involve known and unknown risks and uncertainties and other factors that may cause the actual results to be materially different from the results implied herein. In particular, there are no assurances that: (i) the United States Patents and Trademarks Office will grant Caleco Pharma a patent in connection with its current patent applications; (ii) Caleco Pharma will be able to manufacture and produce its products or that its products will be effective; or (iii) it will be able to carry out any pre-clinical or clinical trials of its products. Readers are cautioned not to place undue reliance on the forward-looking statements made in this press release.
FOR FURTHER INFORMATION PLEASE CONTACT:
Caleco Pharma Corp.
John Boschert
(360) 306-1133
BlueWater Advisory Group - Investor Relations
Bryan Crane
Managing Director
(805) 426-5090
“Stock Pick” Update
Axial Vector Energy
News Released Yesterday
Next Generation Bio-Fuels Produce Excellent Power in Axial Vector Family of Engines
It appears that investors have grown tired of hearing what Axial Vector engines are capable of doing and instead want them to “SHOW ME THE MONEY”. We all know that AVEC engines can run on just about any kind of bio-fuel right on down to elbow grease. I guess what we really want to see is a major contract with big dollars attached.
We all were impressed to see that Kirloskar of India is interested in manufacturing some of the engines. Now, what do we get as an encore? AXVC stock has dropped all the way back down to about .12 per share due in part to unnecessary news releases. The public wants to see real progress on a number of fronts. Regardless, the stock is getting oversold again and may be very close to a good buy point yet again. Stay tuned for more on this saga!
Feb 8, 2010 5:56:00 AM EST
DUBAI, UAE -- (MARKET WIRE) - Axial Vector Energy Corporation ("AVEC") (PINKSHEETS: AXVC) (FRANKFURT: BAE1) confirmed today its family of marine/aviation/heavy industry engines are capable of producing excellent power cycles using next generation bio-fuels, in addition to today's bio-fuels, such as palm oil and corn ethanol, as well as other cropped-based fuels.
With the addition of our 352hp / 1710 ft-lb of torque work horse engine, now being made ready for mass production, combined with our 240hp / 1140 ft-lb of torque 'gas cam marine/aviation engine,' Axial Vector has the only engines capable of using all fuels 'hydrocarbon,' 'alternative fuels,' and 'next generation bio-fuels’.
Today, the United States produces 12 billion gallons of bio-fuels, with that number scheduled to grow to 36 billion gallons by 2022 as mandated in the 2007 Energy Bill. Sanjai Chhaunker, President & CEO, stated, "Our engines are the perfect bridge between the needs of today and the demands of tomorrow. We use 30% less hydrocarbon fuel when creating power and have the ability to use today's and tomorrow's bio-fuels including ethanol substitutes and isobutanol [Modified e-coli and glucose (sugar) reacts to make isobutanol."
About Axial Vector Energy Corporation
Axial Vector Energy Corporation (AVEC) is a global solutions provider that owns, develops, invests in and licenses revolutionary technologies including internal combustion engine and electric power generator technologies that have unlimited potential in military, industrial and commercial applications. AVEC and its partners are positioned to become unrivalled leaders in international engine and energy markets with technologies that produce more efficient, cost effective, environmentally sensitive and versatile solutions for use in a wide variety of important applications around the world.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, among others, all assumptions, expectations, predictions, intentions or beliefs about future events. You are cautioned that any such forward-looking statements are not guarantees of future performance and that a number of risks and uncertainties could cause actual results of the Company to differ materially from those anticipated, expressed or implied in the forward-looking statements. The words "believe," "expect," "anticipate," "project," "targets," "optimistic," "intend," "aim," "will" or similar expressions are intended to identify forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Risks and uncertainties that could cause actual results to differ materially from those anticipated include risks related to new and existing products, product defects and any related product recall; any projections of sales, earnings, revenue, margins or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements regarding future economic conditions or performance; uncertainties related to conducting business in China; any statements of belief or intention; any of the factors and risks mentioned in the "Risk Factors" section of our Annual Report on Form 10-K for the year ended December 31, 2007 and any subsequent SEC filings. The Company assumes no obligation and does not intend to update any forward-looking statements, except as required by law.
For further information, please contact:
Samuel Higgins
Chairman
Axial Vector Energy Corporation
Telephone: +9714 887 5351
Facsimile: +9714 881 7835
Jebel Ali Free Zone
LOB21- F07
Dubai, United Arab Emirates
Building # 1, 1397 Taylor Farm Road
Virginia Beach, VA 23453
United States
TheGreenBaron.com • EvergreenMarketingInc.com • Disclaimer • Remove Me